Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design
Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design have?
Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design has 99 citations in the OpenAlex counts ScholarIQ stores.
When was Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design published?
Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design has 2022 year in the ScholarIQ index.
What is the open-access status of Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design?
Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design has green oa status in the ScholarIQ index.
What is the DOI of Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design?
The DOI for Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design is on the source record.
What is the PMID of Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design?
The PMID for Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design is on the source record.
What is the OpenAlex record for Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design?
The OpenAlex for Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design is on the source record.